← Back to All Filings

Roivant Sciences Reports 2026 Annual General Meeting Voting Results

Low SignificanceSeptember 18, 2026 at 11:49:26 AM UTC

Roivant Sciences Ltd.

$ROIV8-KCIK: 0001635088

Subscribe to track ROIV

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

šŸ“‹ Roivant Sciences Ltd. ($ROIV) Files Form 8-K: Voting Results • Event: 2026 Annual General Meeting of Shareholders held September 16, 2026 • Quorum: ~90.3% of eligible common shares represented (652,143,869 shares) • Proposal 1: Daniel Gold and Meghan FitzGerald re-elected as Class II directors • Proposal 2: Ernst & Young LLP ratified as independent auditor • Proposal 3: Advisory vote on executive compensation (Say-on-Pay) approved

Comprehensive Analysis

Executive Summary

On September 18, 2026, Roivant Sciences Ltd. (NASDAQ: ROIV) filed a Form 8-K detailing the results of its 2026 Annual General Meeting of Shareholders held on September 16, 2026.

A total of 652,143,869 common shares were represented in person or by proxy, representing approximately 90.3% of the 722,406,273 common shares entitled to vote, thereby constituting a quorum. All three management proposals presented to shareholders were approved.


Voting Results Summary

Proposal 1: Election of Class II Directors

Shareholders voted to re-elect two Class II directors to serve until the annual general meeting following the fiscal year ending March 31, 2029:

  • Daniel Gold:

    • For: 375,791,264
    • Withheld: 210,203,958
    • Broker Non-Votes: 66,148,647
  • Meghan FitzGerald:

    • For: 422,428,908
    • Withheld: 163,566,314
    • Broker Non-Votes: 66,148,647

Proposal 2: Ratification of Independent Registered Public Accounting Firm

Shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm and statutory auditor for the fiscal year ending March 31, 2027:

  • For: 651,315,490
  • Against: 731,364
  • Abstain: 97,015
  • Broker Non-Votes: 0

Proposal 3: Advisory Vote on Executive Compensation (Say-on-Pay)

Shareholders approved, on an advisory non-binding basis, the compensation of named executive officers:

  • For: 316,702,500
  • Against: 269,062,122
  • Abstain: 230,600
  • Broker Non-Votes: 66,148,647

Note: While approved, the Say-on-Pay proposal experienced a notable level of opposition, passing with approximately 54.1% of votes cast in favor (excluding abstentions and broker non-votes).


Market & Governance Impact

  • Trading Significance: Low. The outcomes represent routine annual corporate governance actions without material surprises to operations or corporate capital structure.
  • Notable Governance Observation: The relatively narrow margin on Proposal 3 (Say-on-Pay) and sizeable withheld votes on Class II directors indicate elevated shareholder scrutiny regarding executive compensation programs.
Topics:#ROIV#RoivantSciences#CorporateGovernance#SEC#AnnualMeeting

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.